{
  "ticker": "VRTX",
  "company": "Vertex Pharmaceuticals",
  "quarter": "Q3 2025",
  "date": "2025-07-28",
  "content": "Vertex Pharmaceuticals Financial Overview\nData as of: 2025-07-28\n\nCompany Metrics:\nStock Price: $273.30\nMarket Cap: $88,298,071,717\n52-Week High: $355.29\n52-Week Low: $191.31\n\nValuation Metrics:\nP/E Ratio (TTM): 44.4\nForward P/E: 39.9\nPEG Ratio: 0.50\nPrice to Book: 6.3\n\nFinancial Performance:\nRevenue (TTM): $7,593,838,670\nRevenue Growth (YoY): -8.4%\nGross Margin: 20.6%\nOperating Margin: 10.2%\nNet Margin: 1.7%\n\nProfitability:\nReturn on Assets: 16.6%\nReturn on Equity: 29.0%\nProfit Margin: 1.7%\n\nTrading Information:\nBeta: 1.12\nDividend Yield: 1.49%\nPrevious Close: $267.84\nDay Range: $265.10 - $278.77\nVolume: 2,407,195\nAverage Volume: 5,133,715",
  "source": "batch-cache",
  "cached_at": "2025-07-28T21:15:02.679453"
}